Cost-effectiveness findings not based on available evidence. [electronic resource]
- The Medical journal of Australia Sep 2004
- 339; author reply 339-40 p. digital
Publication Type: Comment; Comparative Study; Letter
0025-729X
10.5694/j.1326-5377.2004.tb06307.x doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects Cost-Benefit Analysis Cyclooxygenase Inhibitors--administration & dosage Drug Costs Drug Industry Evidence-Based Medicine Humans Sensitivity and Specificity United States United States Food and Drug Administration